Genmab A/S Q4 2021 Earnings Call Transcript - Thomson StreetEvents

Genmab A/S Q4 2021 Earnings Call Transcript

Genmab A/S Q4 2021 Earnings Call Transcript - Thomson StreetEvents
Genmab A/S Q4 2021 Earnings Call Transcript
Published Feb 16, 2022
Published Feb 16, 2022
Price US$ 54.00  |  Buy this Report Now

About This Report

  
Abstract:

Edited Transcript of GMAB.CO earnings conference call or presentation 16-Feb-22 5:00pm GMT

  
Report Type:

Transcript

Source:
Thomson StreetEvents
Company:
Genmab A/S
Ticker
GMAB.CO
Time
5:00pm GMT
Format:
PDF Adobe Acrobat
Buy Now

The following is excerpted from the question-and-answer section of the transcript.

(Questions from industry analysts are provided in full, but answers are omitted - download the transcript to see the full question-and-answer session)

Question: Xian Deng - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst : It's Xian from Berenberg. So I have a question on the epcoritamab Phase III trial design in frontline DLBCL. So really just wondering if there's any color you could give us on the potential trial design for frontline DLBCL. Anything you could share in terms of combination partners or control arm? And actually, logistically, just wondering, can you actually run a frontline trial involving Polivy? Or do you have to wait on to FDA approved for use of Polivying frontline DLBCL? Is that by any chance of gating item for you?

Question: Xian Deng - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst : Yes. Actually, just wondering, is it possible to actually run the trial, including (inaudible) it's actually approved in frontline -- it is logistically possible? REFINITIV STREETEVENTS | www.refinitiv.com | Contact Us consent of Refinitiv. 'Refinitiv' and the Refinitiv logo are registered trademarks of Refinitiv and its affiliated companies. FEBRUARY 16, 2022 / 5:00PM, GMAB.CO - Q4 2021 Genmab A/S Earnings Call

Question: Xian Deng - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst : Yes, theoretically.

Question: Xian Deng - Joh. Berenberg, Gossler & Co. KG, Research Division - Analyst : Understood. Thank you very much.

Table Of Contents

Genmab A/S at Morgan Stanley Global Healthcare Conference Transcript – 2022-09-13 – US$ 54.00 – Edited Transcript of GMAB.CO presentation 13-Sep-22 12:00pm GMT

Genmab A/S Q2 2022 Earnings Call Transcript – 2022-08-10 – US$ 54.00 – Edited Transcript of GMAB.CO earnings conference call or presentation 10-Aug-22 4:00pm GMT

Genmab A/S at Goldman Sachs Global Healthcare Conference Transcript – 2022-06-15 – US$ 54.00 – Edited Transcript of GMAB.CO presentation 15-Jun-22 8:20pm GMT

Genmab A/S Q1 2022 Earnings Call Transcript – 2022-05-11 – US$ 54.00 – Edited Transcript of GMAB.CO earnings conference call or presentation 11-May-22 4:00pm GMT

Genmab A/S Annual Shareholders Meeting Transcript – 2022-03-29 – US$ 54.00 – Edited Transcript of GMAB.CO shareholder or annual meeting 29-Mar-22 12:00pm GMT

Genmab A/S at JPMorgan Healthcare Conference (Virtual) Transcript – 2022-01-12 – US$ 54.00 – Edited Transcript of GMAB.CO presentation 12-Jan-22 2:00pm GMT

Genmab A/S Virtual R&D Update and ASH Data Review Transcript – 2021-12-14 – US$ 54.00 – Edited Transcript of GMAB.CO corporate analyst meeting</ 14-Dec-21 7:00pm GMT

Genmab A/S Q3 2021 Earnings Call Transcript – 2021-11-10 – US$ 54.00 – Edited Transcript of GMAB.CO earnings conference call or presentation 10-Nov-21 5:00pm GMT

Genmab A/S at Morgan Stanley Global Healthcare Conference (Virtual) Transcript – 2021-09-09 – US$ 54.00 – Edited Transcript of GMAB.CO presentation 9-Sep-21 12:00pm GMT

Genmab A/S Q2 2021 Earnings Call Transcript – 2021-08-11 – US$ 54.00 – Edited Transcript of GMAB.CO earnings conference call or presentation 11-Aug-21 4:00pm GMT

More from Thomson StreetEvents

Thomson StreetEvents—Thomson StreetEvents is a leading provider of Web-based solutions for the investment community, offering services that transform the way companies communicate and meet disclosure requirements while assisting investors in managing and leveraging this information. Thomson StreetEvents service offers institutional investors a one-stop solution for managing corporate disclosure information by aggregating conference calls, webcasts, transcripts, call summaries, and other financial information into a time-saving, efficiency tool.
Purchase Thomson StreetEvents' Transcripts (verbatim reports) and Briefs (call summaries) of earnings, guidance, M&A and other corporate calls directly through Alacra. Discounted prices apply to reports produced over two weeks ago.

About the Author


Cite this Report

  
MLA:
Thomson StreetEvents. "Genmab A/S Q4 2021 Earnings Call Transcript" Feb 16, 2022. Alacra Store. Nov 06, 2026. <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2021-Genmab-A-S-Earnings-Call-T15107110>
  
APA:
Thomson StreetEvents. (2022). Genmab A/S Q4 2021 Earnings Call Transcript Feb 16, 2022. New York, NY: Alacra Store. Retrieved Nov 06, 2026 from <http://www.alacrastore.com/thomson-streetevents-transcripts/Q4-2021-Genmab-A-S-Earnings-Call-T15107110>
  
US$ 54.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.